Practical Approaches to Clinical Trials in Non-muscle-Invasive Bladder Cancer

Robert S. Svatek, John A. Taylor

Producción científica: Chapter


The randomized controlled trial is a relatively new method for assessing the efficacy of an intervention in the field of urology. Randomized controlled trials address inherent biases through allocation of concealment but are still subject to important biases and limitations. Non-muscle-invasive bladder cancer trials include both adjuvant and non-adjuvant therapeutic trials which have unique outcomes and methodology. Here, we review important biases, endpoints, and aspects of clinical trial design in non-muscle-invasive bladder cancer as well as explore the underpinnings of pivotal trials that changed management for this disease.

Idioma originalEnglish (US)
Título de la publicación alojadaBladder Cancer
Subtítulo de la publicación alojadaA Practical Guide
EditorialSpringer International Publishing
Número de páginas8
ISBN (versión digital)9781484271070
ISBN (versión impresa)9781484271063
EstadoPublished - ene 1 2021

ASJC Scopus subject areas

  • General Medicine


Profundice en los temas de investigación de 'Practical Approaches to Clinical Trials in Non-muscle-Invasive Bladder Cancer'. En conjunto forman una huella única.

Citar esto